As the only national nonprofit advocacy organization focused on hereditary breast and ovarian cancer, FORCE has a strong commitment to promoting research.
Full study details on clinicaltrials.gov
Name of PARP Inhibitor used in study:
Type of study:
Participants will be assigned to one of two groups
Thomas Jefferson University
Contact: Tiffany Avery, MD, MPH 215-955-1661
Contact: Clinical Research Management Office 215-955-1661